欧洲癌症研究和治疗组织生活质量问卷核心15的评估姑息治疗和慢性疾病治疗的功能评估-姑息治疗在评估晚期癌症患者的生活质量。

IF 1.9 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
Paula Tur, Eva Oldenburger, Andrew Bottomley, David Cella, Shing Fung Lee, Adrian W Chan, Gustavo Nader Marta, Timothy Jacobs, Edward Chow, Henry C Y Wong, Agata Rembielak
{"title":"欧洲癌症研究和治疗组织生活质量问卷核心15的评估姑息治疗和慢性疾病治疗的功能评估-姑息治疗在评估晚期癌症患者的生活质量。","authors":"Paula Tur, Eva Oldenburger, Andrew Bottomley, David Cella, Shing Fung Lee, Adrian W Chan, Gustavo Nader Marta, Timothy Jacobs, Edward Chow, Henry C Y Wong, Agata Rembielak","doi":"10.1097/SPC.0000000000000750","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Two widely validated health-related quality of life (HR-QoL) tools, specifically designed for patients with advanced cancer, are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 15 Palliative Care (EORTC QLQ-C15-PAL) and the Functional Assessment of Chronic Illness Therapy-Palliative (FACIT-Pal-14). This systematic review aims to evaluate the use of EORTC QLQ-C15-PAL and FACIT-Pal-14 in prospective studies in patients with advanced cancer, focusing on study types, clinical settings, additional HR-QoL tools used, and completion rates.</p><p><strong>Recent findings: </strong>Sixty studies were included in the analysis. Both EORTC QLQ-C15-PAL and FACIT-Pal-14 are used in a variety of studies. Given that EORTC QLQ-C15-PAL was developed 9 years before FACIT-Pal-14 PAL, most studies utilized the EORTC tool. Both tools were shown to be successfully used in a variety of clinical settings, including in various advanced tumour types or different study designs, depending on the investigator and study needs.</p><p><strong>Summary: </strong>This review demonstrates the wide range of utilization of EORTC QLQ-C15-PAL and FACIT-Pal-14 in prospective studies to assess the HR-QoL issues in patients with advanced cancers.</p>","PeriodicalId":48837,"journal":{"name":"Current Opinion in Supportive and Palliative Care","volume":" ","pages":"130-137"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the EORTC QLQ-C15-PAL and the FACIT-PAL-1 in assessing the quality of life in patients with advanced cancer.\",\"authors\":\"Paula Tur, Eva Oldenburger, Andrew Bottomley, David Cella, Shing Fung Lee, Adrian W Chan, Gustavo Nader Marta, Timothy Jacobs, Edward Chow, Henry C Y Wong, Agata Rembielak\",\"doi\":\"10.1097/SPC.0000000000000750\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>Two widely validated health-related quality of life (HR-QoL) tools, specifically designed for patients with advanced cancer, are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 15 Palliative Care (EORTC QLQ-C15-PAL) and the Functional Assessment of Chronic Illness Therapy-Palliative (FACIT-Pal-14). This systematic review aims to evaluate the use of EORTC QLQ-C15-PAL and FACIT-Pal-14 in prospective studies in patients with advanced cancer, focusing on study types, clinical settings, additional HR-QoL tools used, and completion rates.</p><p><strong>Recent findings: </strong>Sixty studies were included in the analysis. Both EORTC QLQ-C15-PAL and FACIT-Pal-14 are used in a variety of studies. Given that EORTC QLQ-C15-PAL was developed 9 years before FACIT-Pal-14 PAL, most studies utilized the EORTC tool. Both tools were shown to be successfully used in a variety of clinical settings, including in various advanced tumour types or different study designs, depending on the investigator and study needs.</p><p><strong>Summary: </strong>This review demonstrates the wide range of utilization of EORTC QLQ-C15-PAL and FACIT-Pal-14 in prospective studies to assess the HR-QoL issues in patients with advanced cancers.</p>\",\"PeriodicalId\":48837,\"journal\":{\"name\":\"Current Opinion in Supportive and Palliative Care\",\"volume\":\" \",\"pages\":\"130-137\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Opinion in Supportive and Palliative Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/SPC.0000000000000750\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Supportive and Palliative Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SPC.0000000000000750","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

综述目的:两个广泛验证的健康相关生活质量(HR-QoL)工具,专门为晚期癌症患者设计,是欧洲癌症研究与治疗组织(EORTC)生活质量问卷核心15姑息治疗(EORTC QLQ-C15-PAL)和慢性疾病治疗-姑息治疗功能评估(FACIT-Pal-14)。本系统综述旨在评估EORTC QLQ-C15-PAL和FACIT-Pal-14在晚期癌症患者前瞻性研究中的使用情况,重点关注研究类型、临床环境、使用的其他HR-QoL工具和完成率。最新发现:60项研究被纳入分析。EORTC QLQ-C15-PAL和FACIT-Pal-14都被用于各种研究。考虑到EORTC QLQ-C15-PAL比FACIT-Pal-14 PAL早9年开发,大多数研究使用EORTC工具。这两种工具都被证明可以成功地用于各种临床环境,包括各种晚期肿瘤类型或不同的研究设计,这取决于研究者和研究需要。摘要:本文综述了EORTC QLQ-C15-PAL和FACIT-Pal-14在评估晚期癌症患者HR-QoL问题的前瞻性研究中的广泛应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of the EORTC QLQ-C15-PAL and the FACIT-PAL-1 in assessing the quality of life in patients with advanced cancer.

Purpose of review: Two widely validated health-related quality of life (HR-QoL) tools, specifically designed for patients with advanced cancer, are the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 15 Palliative Care (EORTC QLQ-C15-PAL) and the Functional Assessment of Chronic Illness Therapy-Palliative (FACIT-Pal-14). This systematic review aims to evaluate the use of EORTC QLQ-C15-PAL and FACIT-Pal-14 in prospective studies in patients with advanced cancer, focusing on study types, clinical settings, additional HR-QoL tools used, and completion rates.

Recent findings: Sixty studies were included in the analysis. Both EORTC QLQ-C15-PAL and FACIT-Pal-14 are used in a variety of studies. Given that EORTC QLQ-C15-PAL was developed 9 years before FACIT-Pal-14 PAL, most studies utilized the EORTC tool. Both tools were shown to be successfully used in a variety of clinical settings, including in various advanced tumour types or different study designs, depending on the investigator and study needs.

Summary: This review demonstrates the wide range of utilization of EORTC QLQ-C15-PAL and FACIT-Pal-14 in prospective studies to assess the HR-QoL issues in patients with advanced cancers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Opinion in Supportive and Palliative Care
Current Opinion in Supportive and Palliative Care HEALTH CARE SCIENCES & SERVICES-
CiteScore
3.70
自引率
0.00%
发文量
54
期刊介绍: A reader-friendly resource, Current Opinion in Supportive and Palliative Care provides an up-to-date account of the most important advances in the field of supportive and palliative care. Each issue contains either two or three sections delivering a diverse and comprehensive coverage of all the key issues, including end-of-life management, gastrointestinal systems and respiratory problems. Current Opinion in Supportive and Palliative Care is an indispensable journal for the busy clinician, researcher or student.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信